Caris Life Sciences, Inc. (CAI)
19.53
-1.32
(-6.33%)
USD |
NASDAQ |
Feb 20, 16:00
19.52
-0.01
(-0.05%)
After-Hours: 20:00
Caris Life Sciences EPS Diluted (Quarterly) : 0.0862 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.482 |
| Glaukos Corp. | -2.324 |
| Edgewise Therapeutics, Inc. | -0.3855 |
| Nuvalent, Inc. | -1.697 |
| Alphatec Holdings, Inc. | -0.1888 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.32M |
| Revenue (Quarterly) | 216.83M |
| Total Expenses (Quarterly) | 192.51M |
| Enterprise Value | 5.180B |
| Gross Profit Margin (Quarterly) | 68.03% |
| Profit Margin (Quarterly) | 11.22% |
| Earnings Yield | -12.42% |
| Normalized Earnings Yield | -11.69 |